Abeloff's Clinical Oncology Review E-Book, 5th Edition

Authors :
John E. Niederhuber & James O. Armitage & James H Doroshow & Michael B. Kastan & Joel E. Tepper
Date of Publication: 11/2013

Practical and clinically focused, Abeloff’s Clinical Oncology Review is designed to help you master the latest scientific discoveries and their implications for cancer diagnosis and management in the most accessible manner possible: on your favo......view more

Add to Cart

Practical and clinically focused, Abeloff’s Clinical Oncology Review is designed to help you master the latest scientific discoveries and their implications for cancer diagnosis and management in the most accessible manner possible: on your favorite eReader! This new eBook, ideal for fast access and portability, equips you with the core knowledge you need to pass the oncology boards. It's your complete board review package!


Key Features
  • Efficiently review the latest developments in cancer pharmacology, oncology and healthcare policy, survivorship in cancer, and many other timely topics, all in the convenience of an eBook – perfect for study on the go!
  • Quickly and effortlessly access the core, distilled, scientific and clinical oncology know-how you need with key points from Abeloff's famed "Blue Boxes" at the beginning of each chapter.
  • Test your mastery with 500 interactive multiple-choice oncology review questions and answers.
  • Reinforce your knowledge with this ideal review companion to Abeloff's Clinical Oncology, 5th Edition (ISBN: 978-1-4557-2865-7).
  • Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability. Compatible with Kindle®, nook®, and other popular devices.

Author Information
By John E. Niederhuber, MD, Adjunct Professor, Departments of Surgery and Oncology; Deputy Director, The Johns Hopkins Clinical Research Network, Johns Hopkins University School of Medicine, Baltimore, Maryland ; James O. Armitage, MD, Joe Shapiro Professor of Medicine, University of Nebraska Medical Center, Omaha, Nebraska; James H Doroshow, MD, Bethesda, Maryland; Michael B. Kastan, MD, PhD, Executive Director, Duke Cancer Institute; William W. Shingleton Professor, Pharmacology and Cancer Biology, Durham, North Carolina and Joel E. Tepper, MD, Hector MacLean Distinguished Professor of Cancer Research, Department of Radiation Oncology, University of North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina